| 专论编号 | 物质名称 | 证书持有人 | 持有人ORG-ID和LOC-ID | 证书编号 | 发布日期 | 证书状态 | 到期续期 | 证书结束日期 | 证书类型 | 上一程序的结束日期 | 历史数据 程序类型|结论|日期 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1362 | Prilocaine | NORTEC QUIMICA S.A. Duque de Caxias BR | 100003647;100007647 | CEP 2019-135 - Rev 01 | 2026/04/17 | Valid | Chemical | 2026/04/17 | Renewal|CEP granted|17/04/2026 | ||
| 627 | Nifedipine | SHOUGUANG FUKANG PHARMACEUTICAL CO., LTD. Shouguang CN | 100017920;100052986 | CEP 2022-402 - Rev 01 | 2026/04/17 | Valid | 22/04/2029 | Chemical | 2026/04/17 | Monograph revision|CEP granted|17/04/2026; New application|CEP granted|22/04/2024 |
|
| 1800 | Vincamine | LINNEA S.A. Locarno CH | 100018975;100027746 | CEP 2022-273 - Rev 01 | 2026/04/17 | Valid | 25/06/2029 | Chemical | 2026/04/17 | Minor revision|CEP granted|17/04/2026; Minor revision|Accepted - CEP remains valid|03/03/2025; New application|CEP granted|25/06/2024 |
|
| 2777 | Pregabalin, PEA Process | MATRIX PHARMACORP PRIVATE LIMITED Sangareddy IN | 100051463;100098142 | CEP 2023-223 - Rev 02 | 2026/04/17 | Valid | 05/02/2029 | Chemical | 2026/04/17 | Minor revision|CEP granted|17/04/2026; Minor revision|Accepted - CEP remains valid|10/03/2025; Notification|CEP granted|29/07/2024; New application|CEP granted|05/02/2024 |
|
| 2631 | Rosuvastatin calcium, Process II | NINGBO MENOVO PHARMACEUTICAL CO., LTD. Ningbo CN | 100030313;100047776 | CEP 2023-095 - Rev 02 | 2026/04/17 | Valid | 05/06/2028 | Chemical | 2026/04/17 | Notification|CEP granted|17/04/2026; Minor revision|Accepted - CEP remains valid|25/06/2024; Minor revision|CEP granted|17/11/2023; New application|CEP granted|05/06/2023 |
|
| 2330 | Leflunomide | BO-CHEM PRIVATE LIMITED Mumbai IN | 100050126;100087586 | CEP 2025-062 - Rev 00 | 2026/04/17 | Valid | 17/04/2031 | Chemical | 2026/04/17 | New application|CEP granted|17/04/2026 | |
| 2335 | Ropivacaine hydrochloride monohydrate | NAVINTA LLC Ewing US | 100045629;100075187 | CEP 2025-463 - Rev 00 | 2026/04/17 | Valid | 17/04/2031 | Chemical | 2026/04/17 | New application|CEP granted|17/04/2026 | |
| 3135 | Rosuvastatin zinc tetrahydrate, Process 2, form I, milled | EGIS PHARMACEUTICALS PLC. Budapest X HU | 100001091;100001662 | CEP 2025-506 - Rev 00 | 2026/04/17 | Valid | 17/04/2031 | Chemical | 2026/04/17 | New application|CEP granted|17/04/2026 | |
| 2338 | Mirtazapine | MEGAFINE PHARMA PRIVATE LIMITED Mumbai IN | 100011550;100021133 | CEP 2024-116 - Rev 01 | 2026/04/17 | Valid | 31/07/2030 | Chemical | 2026/04/17 | Notification|CEP granted|17/04/2026; New application|CEP granted|31/07/2025 |
|
| 463 | Amantadine hydrochloride, Crystalline | ALEMBIC PHARMACEUTICALS LIMITED Vadodara IN | 100006039;100002980 | CEP 2025-168 - Rev 00 | 2026/04/17 | Valid | 17/04/2031 | Chemical | 2026/04/17 | New application|CEP granted|17/04/2026 | |
| 2932 | Rivaroxaban, Form-I | CADILA PHARMACEUTICALS LIMITED Ankleshwar IN | 100003616;100000498 | CEP 2025-140 - Rev 00 | 2026/04/17 | Valid | 17/04/2031 | Chemical | 2026/04/17 | New application|CEP granted|17/04/2026 | |
| 549 | Dexamethasone sodium phosphate | TIANJIN TIANYAO PHARMACEUTICALS CO., LTD. Tianjin CN | 100011805;100018616 | CEP 2013-142 - Rev 01 | 2026/04/16 | Valid | Chemical | 2026/04/16 | Minor revision|CEP granted|16/04/2026 | ||
| 627 | Nifedipine | TAPI NL B.V. Amsterdam NL | 100003852;100094134 | CEP 1999-150 - Rev 07 | 2026/04/16 | Valid | Chemical | 2026/04/16 | Monograph revision|CEP granted|16/04/2026; Notification|CEP granted|04/07/2025; Notification|CEP granted|05/01/2022; Minor revision|CEP granted|17/06/2021 |
||
| 2196 | Bicalutamide | TAPI NL B.V. Amsterdam NL | 100003852;100094134 | CEP 2012-303 - Rev 02 | 2026/04/16 | Valid | Chemical | 2026/04/16 | Minor revision|CEP granted|16/04/2026; Notification|CEP granted|23/11/2021 |
||
| 272 | Doxycycline hyclate | HOVIONE PHARMASCIENCE LIMITED Taipa MO | 100013020;100021389 | CEP 1996-066 - Rev 08 | 2026/04/16 | Valid | Chemical | 2026/04/16 | Minor revision|CEP granted|16/04/2026; Minor revision|CEP granted|18/07/2024; Notification|Accepted - CEP remains valid|14/12/2022; Major revision|CEP granted|04/11/2020 |
||
| 378 | Cetrimide | DISHMAN CARBOGEN AMCIS LIMITED Ahmedabad IN | 100012005;100062133 | CEP 2007-199 - Rev 04 | 2026/04/16 | Valid | Chemical | 2026/04/16 | Minor revision|CEP granted|16/04/2026; Notification|CEP granted|15/07/2024; Minor revision|Accepted - CEP remains valid|22/05/2023; Minor revision|CEP granted|22/06/2022 |
||
| 1794 | Paclitaxel, Produced by fermentation | SAMYANG BIOPHARM CORP. Seongnam-Si KR | 100056631;100101588 | CEP 2009-255 - Rev 03 | 2026/04/16 | Valid | Chemical | 2026/04/16 | Transfer of holdership|CEP granted|16/04/2026; Minor revision|CEP granted|12/08/2021; Minor revision|CEP granted|25/09/2020 |
||
| 654 | Beclometasone dipropionate | INDUSTRIALE CHIMICA S.R.L. Saronno IT | 100011692;100020331 | CEP 2019-108 - Rev 01 | 2026/04/16 | Valid | Chemical | 2026/04/16 | Renewal|CEP granted|16/04/2026 | ||
| 2778 | Sitagliptin phosphate monohydrate | UNION QUIMICO FARMACEUTICA, S.A Barcelona ES | 100000721;100001301 | CEP 2017-252 - Rev 01 | 2026/04/16 | Valid | Chemical | 2026/04/16 | Renewal|CEP granted|16/04/2026 | ||
| 2631 | Rosuvastatin calcium | NINGBO MENOVO PHARMACEUTICAL CO., LTD. Ningbo CN | 100030313;100047776 | CEP 2019-012 - Rev 05 | 2026/04/16 | Valid | Chemical | 2026/04/16 | Notification|CEP granted|16/04/2026; Renewal|CEP granted|25/10/2024; Minor revision|Accepted - CEP remains valid|15/11/2023; Minor revision|Accepted - CEP remains valid|13/05/2022; Minor revision|CEP granted|26/03/2021; Administrative procedure|CEP granted|24/07/2020; Monograph revision|CEP granted|19/06/2020 |
请输入需要查询的英文物质名称,证书持有人,证书编号,专论编号